Etiometry
Etiometry is a Boston-based, privately held clinical intelligence software company that sells an FDA-cleared, AI-driven platform aggregating ICU physiologic data and computing proprietary risk indices, deployed in 175+ ICUs across 50+ hospitals.
- Company typePrivate
- Founded2010
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Etiometry does
Etiometry Inc. is a Boston-based, privately held healthcare software company founded in 2010 that builds an FDA-cleared clinical intelligence platform for high-acuity care teams in hospital intensive care units. Its platform aggregates high-frequency physiologic data from ventilators, bedside monitors, labs, EHR systems, and other sources into a unified visualization layer and computes four FDA-cleared adjunctive risk indices (IDO2 for inadequate oxygen delivery, IVCO2 for inadequate CO2 ventilation, HLA for hyperlactatemia, and ACD for acidosis), plus a newly cleared automated cardiogenic shock classification tool, all derived from more than 150 million hours of de-identified patient data. The company complements these risk analytics with clinical pathway automation aligned to hospital-specific protocols and a quality improvement application, and it integrates directly with Epic and Cerner EHRs.
Etiometry sells exclusively through a direct enterprise sales motion to academic medical centers, children's hospitals, and heart centers, with quote-based annual subscriptions that vary by hospital size and ICU count, bundled with implementation support and an ongoing adoption program. The platform is deployed in more than 175 ICUs across 50+ hospitals globally, holds 11 FDA clearances plus four Health Canada approvals and CE markings, and is protected by ten granted US patents. Its go-to-market is anchored by clinical evidence partnerships with leading institutions such as Boston Children's Hospital, Washington University School of Medicine, UT Southwestern, and Children's National Hospital, which both validate the product and generate the peer-reviewed outcomes that support sales cycles. In 2026 the company announced a strategic partnership with Radiometer Medical ApS to integrate acute care blood gas and electrolyte diagnostics into the platform, extending its ecosystem beyond traditional physiologic monitoring.
Etiometry firmographics
Firmographics- Name
- Etiometry
- Legal name
- Etiometry Inc.
- Website
- https://etiometry.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Etiometry is a Boston-based, privately held clinical intelligence software company that sells an FDA-cleared, AI-driven platform aggregating ICU physiologic data and computing proprietary risk indices, deployed in 175+ ICUs across 50+ hospitals.
- Ownership category
- akta.pro rank
Etiometry industry classification
Industry- Product category
- Clinical Intelligence Software for Critical Care
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Services-Prepackaged Software (7372), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
Keywords
Where Etiometry is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Etiometry business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Clinical Intelligence Software Platform: Etiometry generates revenue through licensing its AI-driven clinical intelligence platform to hospitals and healthcare systems. The platform is sold as a subscription or contract basis with implementation and support services included. Pricing is quote-based and varies by hospital size and ICU count. The company provides ongoing adoption program at no additional cost as part of the contract.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise hospital licensing - custom pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Etiometry product offering
Product offeringCore offering
Etiometry develops and sells an FDA-cleared clinical intelligence platform for hospital intensive care units (ICUs) that aggregates high-frequency physiologic data from ventilators, monitors, labs, and EHR systems. The platform computes FDA-cleared adjunctive risk indices (IDO2, IVCO2, HLA, ACD, and the Cardiogenic Shock Tool), provides data visualization, automates hospital-defined clinical pathways, and supports quality improvement initiatives. It is licensed to academic medical centers, children's hospitals, and cardiac care programs on a subscription basis.
Product overview
Etiometry offers a unified clinical intelligence platform for high-acuity care teams, centered on the Etiometry Platform which consolidates data aggregation and visualization, FDA-cleared risk analytics (IDO2, IVCO2, HLA, ACD, and Cardiogenic Shock indices), clinical pathway automation, and quality improvement modules. The platform is accessed via bedside displays, workstations, central command centers, or EHR single sign-on. The Heart Center Solutions bundle provides specialized cardiac care workflows. All components are built on over 150 million hours of de-identified patient data and are explicitly adjunctive to clinician judgment, not replacing monitoring devices or alarms.
Differentiator
Problem solved
Functional benefit
Products and services
- Etiometry Platform End-to-end FDA-cleared clinical intelligence platform for ICU clinical data collection, analysis, visualization, and archiving. It aggregates data from ventilators, monitors, EHRs, labs, and peripheral devices, and delivers FDA-cleared risk indices, clinical pathway automation, and quality improvement capabilities for high-acuity care teams in academic medical centers and children's hospitals.
- Etiometry IDO2 Index
Quantifiable outcome
- Reduce ICU Length of Stay by up to 36%
- +7 more outcomes
Companies that use Etiometry
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Etiometry technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature8 records
Etiometry partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Radiometer Medical ApScoreRadiometer Medical ApS partnered with Etiometry Inc to integrate acute care diagnostics with AI-based clinical decision-support software. This strategic partnership combines Radiometer's blood gas and electrolyte analyzer technology with Etiometry's clinical intelligence platform to enhance acute care diagnostics workflow.
Scale indicators10 records
Recent moves3 records
Expansion highlights6 records
Etiometry competitors and assessment
Company assessmentBroad incumbents
- Mindray: Mindray is a large global patient monitoring vendor with a significant U.S. acute care presence. It competes for the same ICU monitoring data feeds and is increasingly layering clinical decision-support analytics, paralleling Etiometry's positioning from the hardware side.
- Philips (Patient Monitoring): Philips is a global incumbent in ICU patient monitoring (IntelliVue, PIC iX) and acute care analytics. Comparable to Etiometry as an integrated monitoring-and-analytics platform vendor serving the same ICUs, but at much larger scale and as part of a broader hospital portfolio.
- GE HealthCare: GE HealthCare is a major ICU patient monitoring incumbent (CARESCAPE, ICU central stations) and has been layering analytics and AI onto its monitoring platform. Comparable to Etiometry on the monitoring data layer, though Etiometry's FDA-cleared risk algorithms are more decision-support specialized.
- Baxter International: Baxter acquired Cheetah Medical in 2019 (where Etiometry's CEO Shane Cooke was previously CSO) and now sells the Starling hemodynamic monitoring system. Baxter is a broader medtech incumbent that competes for ICU monitoring and decision-support budget.
- Edwards Lifesciences: Edwards is a dominant hemodynamic monitoring incumbent (FloTrac, ClearSight, HemoSphere) used in the same ICUs where Etiometry's risk indices operate. It competes for clinical attention and budget around advanced ICU monitoring, though its core is hardware sensors rather than analytics software.
- Nihon Kohden: Nihon Kohden is a patient monitoring incumbent with strong neurology and ICU presence, including its own AI-based early warning work. Comparable as a monitoring-plus-analytics vendor serving similar critical-care buyers.
Emerging players
- Hicuity Health: Hicuity Health is one of the largest tele-ICU providers in the U.S., delivering remote critical care services to partner hospitals. It is adjacent rather than directly competitive — Etiometry provides the on-site clinical intelligence platform while Hicuity provides the remote clinician staffing layer — but both target the same ICU outcomes improvement budgets.
- Qventus: Qventus applies AI to hospital operations including ICU flow, length of stay reduction, and discharge planning. It overlaps with Etiometry on AI-driven ICU optimization but is broader in scope (perioperative, inpatient, ED) and less focused on physiology-based risk indices.
Direct peers
- Ambient Clinical Analytics: Ambient Clinical Analytics sells AWARE, an FDA-cleared ICU clinical decision support platform that aggregates bedside data and surfaces critical-care analytics. It directly competes with Etiometry in the same ICU clinical intelligence category.
- Medical Informatics Corp: MIC's Sickbay platform is a clinical decision support and data aggregation platform for ICUs, integrating waveforms and EMR data and providing FDA-cleared analytics. It is the closest head-to-head competitor to Etiometry in ICU clinical intelligence software.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Etiometry social profiles
Digital presenceEtiometry compliance and trust
Trust signalCompliance2 records
Etiometry financial estimates
Financial estimateRevenue estimate
Valuation estimate
Etiometry leadership team
Management profileNumber of profiles
Profiles10 records
Etiometry funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Etiometry M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Etiometry
What does Etiometry do?
Etiometry develops and sells an FDA-cleared clinical intelligence platform for hospital intensive care units (ICUs) that aggregates high-frequency physiologic data from ventilators, monitors, labs, and EHR systems. The platform computes FDA-cleared adjunctive risk indices (IDO2, IVCO2, HLA, ACD, and the Cardiogenic Shock Tool), provides data visualization, automates hospital-defined clinical pathways, and supports quality improvement initiatives. It is licensed to academic medical centers, children's hospitals, and cardiac care programs on a subscription basis.
Is Etiometry a public or private company?
Etiometry is a private company. It is classified as venture growth investor backed and is currently operating.
When was Etiometry founded?
Etiometry was founded in 2010. It employs 11 to 50 people.
Where is Etiometry based?
Etiometry is headquartered in Boston, United States, in the North America region.
How does Etiometry make money?
One revenue line is on record: clinical Intelligence Software Platform.
Who are Etiometry's main competitors?
Broad incumbents on record are Mindray, Philips (Patient Monitoring), GE HealthCare, Baxter International, Edwards Lifesciences and Nihon Kohden. Emerging players are Hicuity Health and Qventus. Direct peers are Ambient Clinical Analytics and Medical Informatics Corp.
Does Etiometry have an API?
No public API is recorded for Etiometry.
What industry is Etiometry in?
Etiometry's product category is Clinical Intelligence Software for Critical Care. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 33451 and its SIC code is 7372.